Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Osteosarcoma 2Water Intoxication 1Psoriasis 1Ototoxicity 1Neoplasm, Residual 1Myasthenia Gravis 1Leukemia 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Dementia 1Central Nervous System Neoplasms 1Breast Neoplasms 1Breast Cancer Organoids 1Alzheimer Disease 1Acute Kidney Injury 1

Interventions

Voriconazole 2Social Determinants of Health 2trastuzumab deruxtecan 1sacituzumab govitecan 1glucarpidase 1denileukin diftitox 1bismuth tripotassium dicitrate 1Ofloxacin 1Metronidazole 1Methotrexate 1Levofloxacin 1Immunotherapy, Adoptive 1Esomeprazole 1Dihydrouracil Dehydrogenase (NADP) 1Clarithromycin 1CTLA-4 Antigen 1Antineoplastic Agents 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Drug-Related Side Effects and Adverse Reactions × Methotrexate × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡